English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Therapeutic Mechanism of Kai Xin San on Alzheimer’s Disease Based on Network Pharmacology and Experimental Validation Journal article
Wang, Kan, Yang, Rong, Chen, Tuan tuan, Qin, Mei rong, Wang, Ping, Kong, Ming wang. Therapeutic Mechanism of Kai Xin San on Alzheimer’s Disease Based on Network Pharmacology and Experimental Validation[J]. Chinese Journal of Integrative Medicine, 2022.
Authors:  Wang, Kan;  Yang, Rong;  Chen, Tuan tuan;  Qin, Mei rong;  Wang, Ping; et al.
Favorite | TC[WOS]:4 TC[Scopus]:4  IF:2.2/2.3 | Submit date：2023/01/30
Alzheimer’s Disease  Chinese Medicine  Experimental Validation  Kai Xin San  Molecular Docking  Network Pharmacology  Tau Protein  
High-throughput screening for amyloid-β binding natural small-molecules based on the combinational use of biolayer interferometry and UHPLC−DAD-Q/TOF-MS/MS Journal article
Guo, Minsong, Zhu, Fengdan, Qiu, Wenqiao, Qiao, Gan, Law, Betty Yuen Kwan, Yu, Lu, Wu, Jianming, Tang, Yong, Yu, Chonglin, Qin, Dalian, Zhou, Xiaogang, Wu, Anguo. High-throughput screening for amyloid-β binding natural small-molecules based on the combinational use of biolayer interferometry and UHPLC−DAD-Q/TOF-MS/MS[J]. Acta Pharmaceutica Sinica B, 2022, 12(4), 1723-1739.
Authors:  Guo, Minsong;  Zhu, Fengdan;  Qiu, Wenqiao;  Qiao, Gan;  Law, Betty Yuen Kwan; et al.
Favorite | TC[WOS]:32 TC[Scopus]:37  IF:14.7/14.1 | Submit date：2023/01/30
Alzheimer's Disease  Biolayer Interferometry  High-throughput Screening  Kai-xin-san  Uhplc−dad-q/tof-ms/ms